top border
top border
Featured Programs
Dr. Levy on Impact of Nivolumab, Pembrolizumab Approvals in NSCLC
Benjamin P. Levy, MD, assistant professor of Medicine, Hematology, and Medical Oncology at Mount Sinai Hospital, discusses how nivolumab (Opdivo) and pembrolizumab (Keytruda) have impacted the treatment landscape of non–small cell lung cancer (NSCLC). View Now

In this segment, Dean F. Bajorin, MD, and Evan Y. Yu, MD, discuss atezolizumab in muscle-invasive bladder cancer. View Now

 

OncLive News Network

Post-Conference Perspectives in Gastrointestinal Cancers

Post-Conference Perspectives in GI Cancers
Ghassan K. Abou-Alfa, MD, and Diane Reidy Lagunes, MD, discuss key findings that came out of the 2017 Gastrointestinal Cancers Symposium in order to provide viewers with practical advice on the current and future application of new information into clinical care.
View Now

Gina Columbus

Gina Columbus reports on the latest news in oncology in this week's edition of OncLive News Network.

Publication Bottom Border
Border Publication